Hideki Yoshida

Kyoto, 6028566, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A potent and selective PHOX2B promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy.

A potent and selective PHOX2B promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 03, 2026

Successful Treatment of Refractory Pediatric TAFRO Syndrome With Combination Chemotherapy: A Case Report.

Successful Treatment of Refractory Pediatric TAFRO Syndrome With Combination Chemotherapy: A Case Report.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: August 22, 2025

Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features.

Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 26, 2025

Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome.

Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome.

Journal: Pediatric blood & cancer

Published: June 12, 2025

Identifying miRNAs as predictive markers of good prognosis in neuroblastoma.

Identifying miRNAs as predictive markers of good prognosis in neuroblastoma.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: January 13, 2025

Myeloproliferative neoplasm harboring both monosomy 7 and an ALK/ROS1 fusion gene: Proposal for a new disease entity.

Myeloproliferative neoplasm harboring both monosomy 7 and an ALK/ROS1 fusion gene: Proposal for a new disease entity.

Journal: EJHaem

Published: November 13, 2024

Pharmacokinetics of melphalan and adverse events in pediatric AML patients receiving a uniform conditioning regimen.

Pharmacokinetics of melphalan and adverse events in pediatric AML patients receiving a uniform conditioning regimen.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: September 30, 2024

A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

Journal: Molecular cancer therapeutics

Published: August 19, 2024

Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells.

Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells.

Journal: Cancer immunology, immunotherapy : CII

Published: August 04, 2024

Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease.

Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease.

Journal: Biomolecules

Published: December 08, 2023

α-Synuclein pathology in Drosophila melanogaster is exacerbated by haploinsufficiency of Rop: connecting STXBP1 encephalopathy with α-synucleinopathies.

α-Synuclein pathology in Drosophila melanogaster is exacerbated by haploinsufficiency of Rop: connecting STXBP1 encephalopathy with α-synucleinopathies.

Journal: Human molecular genetics

Published: November 13, 2023

Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma.

Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma.

Journal: Pediatric blood & cancer

Published: May 31, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026